Survival of Patients with Stage IV Lung Cancer with Diabetes Treated with Metformin

Abstract

Metformin is associated with improved survival among patients with diabetes with stage IV NSCLC, suggesting a potential anticancer effect. Further research should evaluate plausible biologic mechanisms and test the effect of metformin in prospective clinical trials.